135 related articles for article (PubMed ID: 37831911)
41. Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.
Bellocchi C; Ying J; Goldmuntz EA; Keyes-Elstein L; Varga J; Hinchcliff ME; Lyons MA; McSweeney P; Furst DE; Nash R; Crofford LJ; Welch B; Goldin JG; Pinckney A; Mayes MD; Sullivan KM; Assassi S
Arthritis Rheumatol; 2021 Apr; 73(4):660-670. PubMed ID: 33131208
[TBL] [Abstract][Full Text] [Related]
42. Serum concentration of angiopoietin-like protein 4 in patients with systemic sclerosis.
Żółkiewicz J; Stochmal A; Zaremba M; Hoffmann A; Czuwara J; Rudnicka L
Pol Merkur Lekarski; 2021 Feb; 49(289):28-31. PubMed ID: 33713089
[TBL] [Abstract][Full Text] [Related]
43. The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis.
Mouawad JE; Feghali-Bostwick C
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769282
[TBL] [Abstract][Full Text] [Related]
44. JAK inhibitors and systemic sclerosis: A systematic review of the literature.
Moriana C; Moulinet T; Jaussaud R; Decker P
Autoimmun Rev; 2022 Oct; 21(10):103168. PubMed ID: 35944611
[TBL] [Abstract][Full Text] [Related]
45. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
[TBL] [Abstract][Full Text] [Related]
46. Systemic Sclerosis and Serum Content of Transforming Growth Factor.
Majewski D; Majewska KA; Kuznar-Kaminska B; Runowska M; Piorunek T; Batura-Gabryel H; Puszczewicz M
Adv Exp Med Biol; 2019; 1153():63-67. PubMed ID: 30758773
[TBL] [Abstract][Full Text] [Related]
47. Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis.
Bellamri N; Lelong M; Joannes A; Le Tallec E; Jouneau S; Vernhet L; Lescoat A; Lecureur V
Int Immunopharmacol; 2023 Mar; 116():109723. PubMed ID: 36696855
[TBL] [Abstract][Full Text] [Related]
48. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.
Usategui A; Criado G; Izquierdo E; Del Rey MJ; Carreira PE; Ortiz P; Leonard WJ; Pablos JL
Ann Rheum Dis; 2013 Dec; 72(12):2018-23. PubMed ID: 23413283
[TBL] [Abstract][Full Text] [Related]
49. Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis.
Silva IS; Ferreira BH; Almeida CR
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829561
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies.
Lescoat A; Roofeh D; Kuwana M; Lafyatis R; Allanore Y; Khanna D
Clin Rev Allergy Immunol; 2023 Jun; 64(3):239-261. PubMed ID: 34468946
[TBL] [Abstract][Full Text] [Related]
51. Promotion of Myofibroblast Differentiation and Tissue Fibrosis by the Leukotriene B
Liang M; Lv J; Jiang Z; He H; Chen C; Xiong Y; Zhu X; Xue Y; Yu Y; Yang S; Wang L; Li W; Guan M; Wan W; He R; Zou H
Arthritis Rheumatol; 2020 Jun; 72(6):1013-1025. PubMed ID: 31872544
[TBL] [Abstract][Full Text] [Related]
52. Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1.
Lee R; Del Papa N; Introna M; Reese CF; Zemskova M; Bonner M; Carmen-Lopez G; Helke K; Hoffman S; Tourkina E
J Scleroderma Relat Disord; 2019 Jun; 4(2):127-136. PubMed ID: 35382388
[TBL] [Abstract][Full Text] [Related]
53. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
[TBL] [Abstract][Full Text] [Related]
54. A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis.
Bagnato G; Roberts WN; Roman J; Gangemi S
Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28515040
[TBL] [Abstract][Full Text] [Related]
55. Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
Lakota K; Wei J; Carns M; Hinchcliff M; Lee J; Whitfield ML; Sodin-Semrl S; Varga J
Arthritis Res Ther; 2012 May; 14(3):R102. PubMed ID: 22548780
[TBL] [Abstract][Full Text] [Related]
56. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
[TBL] [Abstract][Full Text] [Related]
57. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis.
Maria AT; Toupet K; Maumus M; Fonteneau G; Le Quellec A; Jorgensen C; Guilpain P; Noël D
J Autoimmun; 2016 Jun; 70():31-9. PubMed ID: 27052182
[TBL] [Abstract][Full Text] [Related]
58. Mesenchymal stem cells suppressed skin and lung inflammation and fibrosis in topoisomerase I-induced systemic sclerosis associated with lung disease mouse model.
Ganesan N; Chang YD; Hung SC; Lan JL; Liao JW; Fu ST; Lee CC
Cell Tissue Res; 2023 Feb; 391(2):323-337. PubMed ID: 36447073
[TBL] [Abstract][Full Text] [Related]
59. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
60. The Fra-2 transgenic mouse model of systemic sclerosis.
Maurer B; Distler JH; Distler O
Vascul Pharmacol; 2013 Mar; 58(3):194-201. PubMed ID: 23232070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
